Despite a likely 14% year-over-year increase in second quarter revenues, Fort Myers-based NeoGenomics Inc. expects to post a loss between $0.02 and $0.03 per share, according to a company release.
Continue reading your article with a Business Observer subscription.
What's included:
✓ Unlimited digital access to BusinessObserverFL.com
✓ E-Newspaper app, digital replica of print edition